Compression Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Description
Compression Therapy Market Analysis
The compression therapy market size is USD 4.31 billion in 2025 and is forecast to reach USD 5.55 billion by 2030, translating into a 5.18% CAGR. Sustained demand originates from aging societies, the rising prevalence of venous disorders, and broader acceptance of compression garments in preventive wellness. Institutional confidence is building after Medicare expanded lymphedema coverage in 2024, while elite-sport recovery protocols have given the therapy consumer appeal . Device makers are shifting toward data-enabled products that combine static and dynamic pressure cycles, elevating clinical outcomes and unit prices. Competitive strategies now hinge on regulatory readiness under the European Medical Device Regulation, geographic expansion into Asia-Pacific, and portfolio upgrades that integrate smart textiles and remote monitoring.
Global Compression Therapy Market Trends and Insights
Rising prevalence of venous disorders and lymphedema
Chronic venous insufficiency affects 25 million adults in the United States, creating continuous demand for compression therapy as a first-line intervention . High-pressure graduated stockings prevent post-thrombotic syndrome, and 2025 SCAI clinical guidelines strongly endorse their use for venous ulcers . This formal backing stabilizes procurement plans for hospitals and payers. Persistent therapeutic need produces predictable replacement cycles, allowing manufacturers to plan capacity and sustain the compression therapy market over the long term.
Growing geriatric population
Population aging places structural pressure on vascular health, especially in Asia-Pacific where the 65+ cohort is climbing at 4% annually. Clinical trials show 87.5% of older adults report improved quality of life with pneumatic compression devices. Medicare’s 2024 lymphedema benefit removes cost barriers in the United States. Together, demographic inevitability and policy support ensure expanding uptake of compression solutions for chronic swelling and mobility limitations.
Lack of patient compliance and discomfort during use
Non-adherence remains a clinical hurdle; surveys show many patients discontinue stockings within weeks due to heat and difficulty donning. SIGVARIS counters with moisture-wicking yarns and temperature-regulating finishes that improve wearer experience. Digital companions now track usage and alert clinicians when wear time falls below prescription. As material science advances, the compliance barrier is expected to recede, tempering the negative CAGR impact.
Other drivers and restraints analyzed in the detailed report include:
- Increasing awareness about compression therapy benefits
- Advancements in compression garments
- Limited reimbursement in developing markets
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Static systems accounted for 68.21% of 2024 revenue, giving them the largest compression therapy market share among technologies. Dynamic pumps, though smaller, are charting a 5.91% CAGR as hospitals and home-care providers migrate to devices that tailor pressure cycles. The Kendall SCD SmartFlow platform delivers vascular refill detection to personalize therapy and cut session times. The compression therapy industry is experiencing a technological convergence where smart textiles interface with pneumatic controllers, signaling future hybrid solutions.
Dynamic devices earn premium pricing because clinical studies cite superior edema reduction and patient comfort. Hospital wound centers frequently adopt pneumatic sleeves following ulcer debridement, while home-care agencies lease portable pumps to chronic-swelling patients. Static wraps remain prevalent for their low cost and ease of training, ensuring they retain core demand within the compression therapy market.
Compression garments generated 52.45% of 2024 revenue, cementing their role as the most popular modality for daily use. Graduated stockings constitute the bulk of volume, although torso and arm sleeves are gaining attention among lymphedema patients. Pumps are forecast to post the highest 5.73% CAGR; Tactile Medical’s Nimbl system achieved meaningful limb-volume reductions in 52-week trials. The compression therapy market size for pumps is expanding as payers approve rental reimbursement and remote monitoring assures adherence.
Braces and wraps hold discreet niches, especially within sports orthopedics. Manufacturers often bundle braces with moisture-managing fabrics to attract athletes seeking stabilization and compression in one product. As consumer literacy on prophylactic care rises, product lines diversify to include fashion-oriented compression socks, fueling incremental growth and reinforcing garments’ dominance in the compression therapy market.
The Compression Therapy Market Report is Segmented by Technology (Static Compression Therapy, Dynamic Compression Therapy), Product (Compression Garments, Compression Pumps, Compression Braces), Application (Venous Leg Ulcers, Deep Vein Thrombosis Treatment, and More), End User (Hospitals, Specialty Clinics, Home Care, Others), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America contributed 40.98% of 2024 revenue due to Medicare reimbursement, broad clinical literacy, and well-developed distributor networks. Hospitals replenish stockings every six months, supporting recurring orders that stabilize the compression therapy market. Europe follows with consistent adoption under public health systems; Germany’s statutory funds reimburse two pairs of medical stockings per year, ensuring predictable volume.
Asia-Pacific is forecast for a 5.97% CAGR through 2030. Aging demographics intersect with rising diabetes prevalence, elevating venous and lymphatic complications. Urban hospitals in China now pilot smart-textile stockings, while Japanese home-care providers integrate pneumatic pumps for aged residents. These shifts attract foreign direct investment and spur local manufacturing clusters.
In South America and the Middle East & Africa, growth is tempered by limited reimbursement and import duties. Nonetheless, physician education programs and modular pumps priced for emerging markets are gradually elevating penetration. As these regions upgrade vascular-care infrastructure, the compression therapy market is expected to capture incremental volume gains.
List of Companies Covered in this Report:
- Solventum
- Essity AB (BSN medical)
- medi
- SIGVARIS Group
- Tactile Systems Technology, Inc.
- Arjo AB (ArjoHuntleigh)
- DJO Global (Enovis Corporation)
- Smiths Group
- Hartmann Group
- Julius Zorn GmbH (Juzo)
- Gottfried Medical
- Bio Compression Systems
- Thuasne SAS
- Lohmann & Rauscher
- Cardinal Health
- Molnlycke Health Care
- DeRoyal Industries
- Koya Medical
- Hyperice
- LIPOELASTIC
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
- 1 Introduction
- 1.1 Study Assumptions & Market Definition
- 1.2 Scope of the Study
- 2 Research Methodology
- 3 Executive Summary
- 4 Market Landscape
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rising prevalence of venous disorders and lymphedema
- 4.2.2 Growing geriatric population
- 4.2.3 Increasing awareness about compression therapy benefits
- 4.2.4 Advancements in compression garments
- 4.2.5 Expanding use in sports and fitness recovery
- 4.2.6 Favorable Reimbursement policies in developed markets
- 4.3 Market Restraints
- 4.3.1 Lack of patient compliance and discomfort during use
- 4.3.2 Limited reimbursement in developing markets
- 4.3.3 Availability of alternative therapies
- 4.3.4 High cost of advanced products
- 4.4 Value / Supply-Chain Analysis
- 4.5 Regulatory Outlook
- 4.6 Technological Outlook
- 4.7 Porter's Five Forces Analysis
- 4.7.1 Threat of New Entrants
- 4.7.2 Bargaining Power of Buyers
- 4.7.3 Bargaining Power of Suppliers
- 4.7.4 Threat of Substitutes
- 4.7.5 Competitive Rivalry
- 5 Market Size & Growth Forecasts (Value, USD)
- 5.1 By Technology
- 5.1.1 Static Compression Therapy
- 5.1.2 Dynamic Compression Therapy
- 5.2 By Product
- 5.2.1 Compression Garments
- 5.2.2 Compression Pumps
- 5.2.3 Compression Braces
- 5.3 By Application
- 5.3.1 Venous Leg Ulcers
- 5.3.2 Deep Vein Thrombosis Treatment
- 5.3.3 Lymphedema Treatment
- 5.3.4 Other Applications
- 5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Specialty Clinics
- 5.4.3 Home Care
- 5.4.4 Others
- 5.5 By Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
- 6 Competitive Landscape
- 6.1 Market Concentration
- 6.2 Market Share Analysis
- 6.3 Company Profiles (includes Global level Overview, Market level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments)
- 6.3.1 Solventum
- 6.3.2 Essity AB (BSN medical)
- 6.3.3 medi GmbH & Co. KG
- 6.3.4 SIGVARIS Group
- 6.3.5 Tactile Systems Technology, Inc.
- 6.3.6 Arjo AB (ArjoHuntleigh)
- 6.3.7 DJO Global (Enovis Corporation)
- 6.3.8 Smith & Nephew plc
- 6.3.9 Paul Hartmann AG
- 6.3.10 Julius Zorn GmbH (Juzo)
- 6.3.11 Gottfried Medical, Inc.
- 6.3.12 Bio Compression Systems, Inc.
- 6.3.13 Thuasne SAS
- 6.3.14 Lohmann & Rauscher GmbH & Co. KG
- 6.3.15 Cardinal Health, Inc.
- 6.3.16 Molnlycke Health Care AB
- 6.3.17 DeRoyal Industries, Inc.
- 6.3.18 Koya Medical
- 6.3.19 Hyperice
- 6.3.20 LIPOELASTIC
- 7 Market Opportunities & Future Outlook
- 7.1 White-space & Unmet-Need Assessment
Pricing
Currency Rates
